Canandaigua National Bank & Trust Co. lifted its stake in shares of HCA Healthcare, Inc. (NYSE:HCA – Free Report) by 49.8% during the third quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 6,255 shares of the company’s stock after purchasing an additional 2,079 shares during the period. Canandaigua National Bank & Trust Co.’s holdings in HCA Healthcare were worth $2,669,000 at the end of the most recent quarter.
A number of other large investors have also made changes to their positions in the company. Rosenberg Matthew Hamilton grew its position in HCA Healthcare by 8.0% during the 3rd quarter. Rosenberg Matthew Hamilton now owns 964 shares of the company’s stock worth $411,000 after purchasing an additional 71 shares in the last quarter. Park National Corp OH boosted its position in HCA Healthcare by 54.2% during the 3rd quarter. Park National Corp OH now owns 17,851 shares of the company’s stock worth $7,618,000 after acquiring an additional 6,276 shares during the period. Partnership Wealth Management LLC purchased a new stake in shares of HCA Healthcare in the third quarter worth approximately $312,000. CapWealth Advisors LLC lifted its position in HCA Healthcare by 1.4% in the 3rd quarter. CapWealth Advisors LLC now owns 4,553 shares of the company’s stock worth $1,943,000 after buying an additional 62 shares in the last quarter. Finally, First Citizens Financial Corp purchased a new stake in shares of HCA Healthcare during the third quarter worth $225,000. Institutional investors and hedge funds own 62.73% of the company’s stock.
Analyst Upgrades and Downgrades
Several brokerages have recently issued reports on HCA. BMO Capital Markets began coverage on HCA Healthcare in a report on Tuesday, September 22nd. They set an “outperform” rating and a $495.00 price target for the company. Deutsche Bank Aktiengesellschaft set a $476.00 price target on shares of HCA Healthcare in a report on Monday, July 27th. UBS Group reduced their price target on HCA Healthcare from $635.00 to $579.00 and set a “buy” rating for the company in a research report on Monday, July 27th. The Goldman Sachs Group decreased their target price on HCA Healthcare from $558.00 to $485.00 and set a “buy” rating for the company in a research report on Tuesday, July 28th. Finally, Oppenheimer lowered their target price on shares of HCA Healthcare from $520.00 to $485.00 and set an “outperform” rating on the stock in a research note on Monday, July 27th. Fifteen research analysts have rated the stock with a Buy rating, eight have given a Hold rating and one has assigned a Sell rating to the company. According to MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and a consensus price target of $466.35.
HCA Healthcare Stock Up 1.5%
HCA Healthcare stock traded up $6.36 during mid-day trading on Wednesday, reaching $438.56. The company had a trading volume of 998,798 shares, compared to its average volume of 1,347,548. The company has a 50 day moving average of $418.32 and a 200-day moving average of $420.54. The firm has a market cap of $94.95 billion, a price-to-earnings ratio of 14.68, a PEG ratio of 1.47 and a beta of 1.10. HCA Healthcare, Inc. has a 52 week low of $353.99 and a 52 week high of $556.52.
HCA Healthcare (NYSE:HCA – Get Free Report) last released its earnings results on Friday, July 24th. The company reported $7.59 earnings per share for the quarter, topping analysts’ consensus estimates of $7.56 by $0.03. The business had revenue of $20.23 billion for the quarter, compared to the consensus estimate of $19.76 billion. HCA Healthcare had a negative return on equity of 244.79% and a net margin of 8.77%.The firm’s revenue for the quarter was up 8.7% compared to the same quarter last year. During the same period last year, the business earned $6.84 earnings per share. On average, analysts predict that HCA Healthcare, Inc. will post 29.42 earnings per share for the current fiscal year.
HCA Healthcare Announces Dividend
The firm also recently announced a quarterly dividend, which was paid on Wednesday, September 30th. Investors of record on Wednesday, September 16th were paid a $0.78 dividend. The ex-dividend date of this dividend was Wednesday, September 16th. This represents a $3.12 dividend on an annualized basis and a yield of 0.7%. HCA Healthcare’s payout ratio is presently 10.45%.
HCA Healthcare Profile
HCA Healthcare, Inc is a provider of healthcare services in the United States. Through its network of hospitals and other healthcare facilities, the company delivers services including emergency and urgent care, surgery, inpatient and outpatient treatment, women’s and children’s care, cardiology, oncology, orthopedics, and behavioral health services.
HCA Healthcare also operates physician practices, ambulatory surgery centers, freestanding emergency rooms, diagnostic facilities, and other outpatient care sites.
Read More
- Five stocks we like better than HCA Healthcare
- Skydance Just Became a Media Giant—With an $80 Billion Debt Load
- Could Velo3D Be the Next Defense Buyout Target?
- Penguin Solutions Is Soaring as AI Memory Demand Explodes
- Alphabet’s Chart Is Coiling—and the Fundamentals May Be Ready to Back It Up
Want to see what other hedge funds are holding HCA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for HCA Healthcare, Inc. (NYSE:HCA – Free Report).
Receive News & Ratings for HCA Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.
